Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAR110894 in mild to moderate Alzheimer's disease
NCT01266525Phase 2Completed
- Sponsor
- Sanofi
- Start
- Feb 2011
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of SAR110894 in Alzheimer's disease (AD), sponsored by Sanofi. Started Feb 2011; status: completed.
02
Drugs
SAR110894
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT01266525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01266525.